National Comprehensive Cancer Network



About NCCN

Head and Neck Cancers Panel - Disclosures as of 2/28/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

David M. Brizel, MD

None

medical legal case unrelated to any nccn activities

None

None

None

Paul M. Busse, MD, PhD

None

None

None

None

None

Jimmy J. Caudell, MD, PhD

None

Boehringer Ingelheim GmbH

None

None

None

Anthony J. Cmelak, MD

None

Amgen Inc.

None

None

None

A. Dimitrios Colevas, MD

Bayer HealthCare;
Boehringer Ingelheim GmbH;
Exelixis Inc.;
Genentech, Inc.;
GlaxoSmithKline;
actogenix;
ecog;
NCI;
rtog

None

None

None

None

Frank Dunphy, MD

Bristol-Myers Squibb Company

None

None

None

None

David W. Eisele, MD, FACS

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Jill Gilbert, MD

National Cancer Institute;
Eastern Cooperative Oncology Group

None

None

None

None

Maura L. Gillison, MD, PhD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Robert I. Haddad, MD

None

None

None

None

None

Bruce H. Haughey, MBChB, MS

None

None

None

None

None

Wesley L. Hicks, MD

None

None

None

None

None

Ying J. Hitchcock, MD

None

None

None

None

None

Miranda Hughes, PhD

None

None

None

None

None

Antonio Jimeno, MD, PhD

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Oncothyreon;
VentiRX Pharmaceuticals

None

None

None

None

Merrill S. Kies, MD

None

None

None

None

None

William M. Lydiatt, MD

None

None

None

None

None

Ellie Maghami, MD

None

None

None

None

None

Renato Martins, MD, MPH

None

None

None

None

None

Thomas McCaffrey, MD, PhD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Nicole McMillian, MS

None

None

None

None

None

Loren K. Mell, MD

None

None

None

None

None

Bharat B. Mittal, MD

None

None

None

None

None

David G. Pfister, MD

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Exelixis Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

None

Harlan A. Pinto, MD

Bristol-Myers Squibb Company

Eli Lilly and Company

None

None

None

John A. Ridge, MD, PhD, FACS

None

None

None

None

None

Sandeep Samant, MD

None

None

None

None

None

David E. Schuller, MD

None

None

None

National Cancer Institute

None

Jatin P. Shah, MD, PhD

None

None

None

None

None

Sharon Spencer, MD

None

None

None

None

None

Sarika Trikha, PharmD

None

None

None

None

None

Randal S. Weber, MD

None

None

None

None

None

Gregory Wolf, MD

None

None

None

None

None

Frank Worden, MD

None

Bristol-Myers Squibb Company

Baxter International Inc.;
Bristol-Myers Squibb Company;
Onyx Pharmaceuticals, Inc.

None

None

Sue S. Yom, MD, PhD

Genentech, Inc.

None

None

None

None